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Glucose is the primary fuel for the brain. It has been 
proposed that the brain senses glucose, and promotes 
eating behaviours when levels are low. A system regulating 
glucose intake, driven by hedonic responses generated in 
the limbic system, has been identified. A taste-independent 
mechanism within the CNS that promotes glucose intake 
has been postulated. 
Glucokinase is a member of the hexokinase family 
of enzymes that convert intracellular glucose to glucose-6 
phosphate. There are two isoforms: the hepatic form, 
expressed in the liver, and the neuroendocrine form 
expressed in the pancreas and the CNS. Both isoforms 
catalyse the same reaction, but utilise different promoters 
and are differentially regulated.
The role of glucokinase in regulating glucose 
homeostasis in the pancreas and liver is well established 
[1]. Within beta cells, glucokinase acts as part of the 
glucose sensing system. Glucose enters the cells via the 
GLUT-2 transporter. It is phosphorylated by glucokinase 
as part of a metabolic pathway which leads to closure of 
ATP-sensitive potassium (KATP) channels. This results 
in cell depolarisation and insulin release. The role of 
glucokinase in the CNS is less clear. Glucokinase is 
expressed in multiple hypothalamic regions, including 
the VMN, PVN & LHA, areas which regulate energy 
homeostasis and are part of the CNS glucose-sensing 
system. A role for hypothalamic glucokinase in the 
regulation of energy homeostasis has been proposed, but 
never confirmed [2]. 
We have recently demonstrated that glucokinase 
activity within the hypothalamic arcuate nucleus is 
involved in regulation of dietary glucose intake [3]. 
We found that in fasted rats, glucokinase activity was 
increased specifically in the arcuate nucleus but not in 
other regions of the hypothalamus. Increased arcuate 
nucleus glucokinase activity increased food intake and 
weight gain in rats. Moreover, it increased glucose intake, 
but not that of fructose. Increased intake of glucose 
occurred in preference to intake of other food types. These 
effects were mimicked by intra-arcuate administration of 
glibenclamide, a drug which blocks the KATP channel. 
Converse effects were obtained by reducing glucokinase 
activity in the arcuate nucleus and with intra-arcuate 
injection of diazoxide, a KATP channel activator. We also 
identified a likely mechanism involving P/Q voltage-
gated calcium channels, NPY release, and action via 
neuropeptide Y receptors. 
Our results suggest that arcuate nucleus glucokinase 
is acting as part of a glucose-sensing system, analogous 
to that in the β cell, as part of a central macronutrient 
regulatory system. A requirement for glucose, rather 
than calories alone, partly drives food intake and arcuate 
nucleus glucokinase can regulate this specific intake 
of glucose. In the absence of a source of pure glucose, 
the increased glucokinase activity in the arcuate nucleus 
drives the intake of mixed nutrient foods. 
This hypothalamic system may form part of the post-
ingestive reward pathway of glucose, or form a separate 
homeostatic regulatory system regulating glucose appetite, 
analogous to that described recently in invertebrates [4]. A 
role in taste-driven intake is less likely, as this is thought 
to be more responsive to fructose and sweeteners, which 
do not appear to activate this glucokinase-based glucose-
sensing system.
The findings of this study fit with those of other 
studies. Hypothalamic glucokinase mRNA expression is 
increased in diet-induced obese and obesity-prone rats [5]. 
Patients with mutations that decrease glucokinase activity 
have reduced body weight [6]. Conversely, patients who 
have mutations associated with increased activity of 
the neuroendocrine form of glucokinase have increased 
body weight [7]. Evidence supports the existence of this 
pathway in humans. This mechanism may explain the 
observation that diets high in carbohydrate are associated 
with weight gain in mice and why low glycemic index 
diets produce weight loss. It also provides a possible CNS 
mechanism to explain the often-described phenomena of 
the “sweet tooth” and carbohydrate craving, particularly 
for high glycemic index foods.
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